![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Hagar’s GWave Glucose Monitor Designated an FDA Breakthrough Device
Hagar’s GWave Glucose Monitor Designated an FDA Breakthrough Device
The FDA has designated Hagar’s GWave noninvasive continuous glucose monitoring system a breakthrough device.
The GWave device is one-third the size of a smartphone and involves less radiofrequency exposure for users than a smartphone, the Israel-based company said.
The device uses radiofrequency waves to measure glucose levels in the blood without the need for a blood sample.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct